Fructose, a common dietary sugar, may play a much larger role in metabolic disease than previously thought. According to a new review published in Nature Metabolism, fructose is not simply another source of calories but may act as a metabolic signal that alters how the body stores fat, uses energy, and regulates blood sugar.
The researchers argue that fructose follows biological pathways that differ substantially from those of glucose. These unique metabolic effects, they suggest, may contribute to obesity, nonalcoholic fatty liver disease, insulin resistance, and other features of metabolic syndrome.
Fructose Follows a Different Metabolic Pathway
The review examined evidence on sugars commonly added to processed foods and beverages, including table sugar and high-fructose corn syrup. Although both contain glucose and fructose, the researchers emphasize that the two sugars are processed differently within the body.
“Fructose is not just another calorie,” said lead author Dr. Richard Johnson of the University of Colorado Anschutz. He describes fructose as a metabolic signal that promotes fat production and storage through mechanisms that differ fundamentally from glucose metabolism.
Unlike glucose, which is tightly regulated by insulin, fructose is primarily metabolized in the liver. According to the review, this allows fructose to bypass some of the body’s normal regulatory systems, rapidly lowering cellular energy stores while stimulating the production of liver fat and triglycerides.
The authors note that these changes may increase uric acid production and oxidative stress, both of which have been linked to metabolic dysfunction. Over time, these processes may contribute to abdominal obesity, elevated blood pressure, abnormal blood lipid levels, and impaired blood sugar regulation—the defining features of metabolic syndrome.
The Body Can Produce Fructose on Its Own
The researchers also point out that fructose does not come exclusively from food. The body can generate fructose internally from glucose through a metabolic pathway known as the polyol pathway.
According to the review, this internal production may increase during periods of high carbohydrate intake, dehydration, or high salt consumption, potentially amplifying the effects of dietary fructose and further increasing the risk of metabolic disease.
An Evolutionary Survival Mechanism
The authors place fructose metabolism within an evolutionary context. They suggest that the ability of fructose to promote fat storage and reduce energy expenditure may once have helped humans survive periods of famine by encouraging the accumulation of energy reserves.
In modern societies, however, these same biological mechanisms may have become maladaptive. With constant access to calorie-dense foods and sugar-sweetened beverages, the metabolic pathways activated by fructose may be stimulated far more frequently than they were during human evolution, contributing to chronic weight gain and metabolic disease.
The review also notes that although sugary beverage consumption has declined modestly in some high-income countries, average intake of free sugars remains above recommended levels for many populations. Meanwhile, sugar consumption continues to increase in many low- and middle-income countries alongside rising rates of obesity and type 2 diabetes.
Implications for Dietary Guidelines
The authors argue that current dietary recommendations may not fully account for the unique biological effects of fructose. They suggest that efforts to reduce sugar consumption should place particular emphasis on sugar-sweetened beverages and highly processed foods that contain concentrated sources of fructose.
Many public health organizations already recommend limiting added sugars to less than 10% of daily calorie intake, while some experts advocate even lower targets. According to the review, policies such as sugar taxes, clearer food labeling, and improved nutrition education could help reduce excessive fructose consumption at the population level.
Johnson and his colleagues acknowledge that further research is needed to clarify how different sources and amounts of fructose affect health in diverse populations. Nevertheless, they argue that recognizing fructose as a key contributor to metabolic disease may improve both prevention strategies and future treatment approaches.
“Understanding how fructose operates at the cellular level may open the door to new therapies,” Johnson said. “But the most immediate step is reducing unnecessary exposure in the diet, especially in children and high-risk groups.”
